2784 results
Risk factors for atherosclerosis

Modifiable risk factors:
 - Dyslipidemia (elevated LDL, decreased HDL)
 - Tobacco smoking
 -
Dyslipidemia (elevated LDL ... , decreased HDL) ... coronary artery disease
Hemoglobin A1c (glycated hemoglobin) reflects the average blood glucose concentration over the course of the RBC
follows: eAG (mg/dL ... correlation with HDL ... cardiovascular diseases ... changes in diabetes treatment ... Digestive and Kidney Diseases
Abnormal Lipid Profiles - Differential Diagnosis Algorithm

Increased Cholesterol and Triglycerides 
 - Genetic Causes
Hypothyroidism Decreased HDL ... • Tangier Disease ... Androgens Increased LDL ... Obstructive Liver Disease
Multiple Myeloma and Monoclonal Gammopathies
C - HyperCalcemia- calcium > 11 mg/dL / >1 mg/dL the ULN
R
/ >1 mg/dL the ... ULN R - Renal disease ... chain deposition disease ... lymphoproliferative diseases ... and autoimmune diseases
Algorithm for the Treatment of Parkinson Disease With Predominant Postural Instability and Gait Impairment

#Management #Neurology #Parkinsons
Algorithm for the Treatment ... of Parkinson Disease ... Neurology #Parkinsons #Disease ... #Medication #Treatment
Treatment Lyme Disease
#Management #LymeDisease #Treatment #Prophylaxis #Early #Late #Curbsiders
Treatment Lyme Disease ... #LymeDisease #Treatment
Rheumatoid Arthritis - ACR 2021 Guidelines
 - Low Disease Activity
 - Moderate to High Disease Activity
Guidelines - Low Disease ... Moderate to High Disease ... Tapering DMARDs - Treatment ... Guidelines #management #treatment
Algorithm for the Treatment of Uremic Pruritus
Nonpharmacologic Treatments:
 • Daily topical emollient
 • Avoidance of extremes
Algorithm for the Treatment ... Nonpharmacologic Treatments ... Pharmacologic Treatments ... Gabapentin 100 mg after HD ... Prebabalin 25 mg after HD
This is an oversimplified, hypothetical model to think about time from symptom onset and stages of
and stages of disease ... determine what treatments ... clinical #management #treatment
Initial treatment of renal bone disease and cinacalcet for secondary hyperparathyroidism
Phosphate binders reduce hyperphosphataemia and hyperparathyroidism.
Initial treatment ... of renal bone disease ... the first-line treatments